Shenzhen Salubris Pharmaceuticals (002294.SZ) plans to repurchase company shares worth 300 million to 500 million yuan.
Xinlitai (002294.SZ) announced that the company plans to repurchase shares through centralized competitive bidding trading, with a total repurchase amount of no less than 300 million yuan (inclusive) and no more than 500 million yuan (inclusive). The source of the repurchase funds will be the company's own funds and self-raised funds, and the repurchase price of the shares will not exceed 45 yuan per share (inclusive). The repurchased shares are intended to be used as a source for later implementation of equity incentive or employee share ownership plans.
Shenzhen Salubris Pharmaceuticals (002294.SZ) announced that the company plans to repurchase shares through centralized bidding trading. The total amount of the repurchase fund will be no less than 300 million yuan, and no more than 500 million yuan. The source of the repurchase funds will be from the company's own funds and self-raised funds, and the repurchase price of the shares will not exceed 45 yuan per share. The repurchased shares are intended to be used as a source for later implementation of stock incentive or employee stock ownership plans.
Related Articles
HANXBIO-B (03378) spent approximately HK$517,600 to repurchase 18,700 shares on June 1st.
Meituan conference call: Expected Q2 food delivery user experience will be significantly better than Q1.
CHERY AUTO(09973): The total sales volume of five major brands in May was 231,900 cars, an increase of approximately 20.7% year-on-year.
HANXBIO-B (03378) spent approximately HK$517,600 to repurchase 18,700 shares on June 1st.
Meituan conference call: Expected Q2 food delivery user experience will be significantly better than Q1.
CHERY AUTO(09973): The total sales volume of five major brands in May was 231,900 cars, an increase of approximately 20.7% year-on-year.
